|
WO2020264039A1
|
|
Artificial antigen-specific immunoregulatory t (airt) cells
|
|
WO2020219425A1
|
|
Combinatorial car t cell and hematopoeitic stem cell genetic engineering for specific immunotherapy of myeloid leukemias
|
|
WO2020190925A1
|
|
Methods and compositions for engineering cd4-deficient car t cells and anti-cd4 car t cells and uses thereof
|
|
WO2020185917A1
|
|
Sodium fluorescein as a reversal agent for an anti-fluorescein car t cells and fluorescein-phospholipid-ethers or profluorescein-phospholipid-ethers
|
|
AU2019333149A1
|
|
Methods and compositions comprising B7H3 chimeric antigen receptors
|
|
WO2020047165A1
|
|
Self-inactivating transposase plasmids and uses thereof
|
|
AU2019319674A1
|
|
Methods and compositions for stimulation of chimeric antigen receptor T cells with hapten labelled cells
|
|
WO2019210057A1
|
|
Rapamycin resistant cells
|
|
CA3091688A1
|
|
Expression of foxp3 in edited cd34+ cells
|
|
AU2019257708A1
|
|
Expression of human FOXP3 in gene edited T cells
|
|
CA3106812A1
|
|
Homology-directed repair template design and delivery to edit hemoglobin-related mutations
|
|
CA3098489A1
|
|
Therapeutic genome editing in x-linked hyper igm syndrome
|
|
EP3765041A1
|
|
Il-13 receptor alpha 2 (il13ra2) chimeric antigen receptor for tumor specific t cell immunotherapy
|
|
AU2019234580A1
|
|
IL-13 receptor alpha 2 targeted, zetakine directed T cell immunotherapy
|
|
EP3749695A1
|
|
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
WO2019038660A1
|
|
Exosome profiling for diagnosis and monitoring of vasculitis and vasculopathies including kawasaki disease
|
|
AU2018270156A1
|
|
Generating mammalian T cell activation inducible synthetic promoters (syn+pro) to improve T cell therapy
|
|
WO2018200597A1
|
|
Homology directed repair compositions for the treatment of hemoglobinopathies
|
|
CA3060570A1
|
|
Therapeutic genome editing in wiskott-aldrich syndrome and x-linked thrombocytopenia
|
|
AU2018256412A1
|
|
Optimized lentiviral vector for XLA gene therapy
|
